Walleye Trading LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,325,335
-23.8%
73,540
-1.7%
0.01%
-33.3%
Q2 2023$3,050,344
-14.1%
74,800
-21.5%
0.01%
+28.6%
Q1 2023$3,551,831
-19.6%
95,300
-24.7%
0.01%
-46.2%
Q4 2022$4,417,074
-32.1%
126,600
+8.9%
0.01%
-35.0%
Q3 2022$6,508,000
+80.7%
116,300
+67.1%
0.02%
+81.8%
Q2 2022$3,602,000
-27.5%
69,600
+1.8%
0.01%
-31.2%
Q1 2022$4,971,000
+13.6%
68,400
+84.9%
0.02%
+6.7%
Q4 2021$4,375,000
-40.5%
37,000
-32.5%
0.02%
-42.3%
Q3 2021$7,350,000
-10.2%
54,791
+8.4%
0.03%
-18.8%
Q2 2021$8,183,000
+274.7%
50,540
+85.8%
0.03%
+220.0%
Q1 2021$2,184,000
+308.2%
27,208
-25.3%
0.01%
+150.0%
Q4 2019$535,000
+276.8%
36,438
+243.8%
0.00%
+300.0%
Q3 2019$142,000
-81.7%
10,600
-76.6%
0.00%
-85.7%
Q1 2019$774,000
+32.3%
45,300
+5.7%
0.01%
+40.0%
Q4 2018$585,000
+145.8%
42,846
+416.2%
0.01%
+150.0%
Q3 2018$238,000
-89.3%
8,300
-89.8%
0.00%
-83.3%
Q2 2018$2,219,000
+281.9%
81,100
+194.4%
0.01%
+200.0%
Q1 2018$581,000
+122.6%
27,551
+104.1%
0.00%
+300.0%
Q4 2017$261,00013,5000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders